Skip to main content

Gila Therapeutics

Minneapolis, United States

Gila Therapeutics is a clinical-stage pharmaceutical company developing a therapy for obesity.

$356K raised
Nov 2022
Seed

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Gila Therapeutics

How much funding has Gila Therapeutics raised?
Gila Therapeutics has raised $356K in total funding. The most recent round was Seed. The last funding was announced in November 2022.
Who are Gila Therapeutics's investors?
Gila Therapeutics's investors include Slater Technology Fund, Broadview Ventures, Argonautic Ventures, Harvard Business School Angels Chicago.
Where is Gila Therapeutics headquartered?
Gila Therapeutics is headquartered in Minneapolis, United States.
What does Gila Therapeutics do?
Gila Therapeutics is a clinical-stage pharmaceutical company developing a therapy for obesity.
What stage is Gila Therapeutics at?
Gila Therapeutics is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Gila Therapeutics — Funding & Investors." VCBacked, November 29, 2022, https://www.vcbacked.co/company/gila-therapeutics. Accessed July 3, 2026.
APA
VCBacked. (2022). Gila Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/gila-therapeutics
Wikipedia (cite web)
{{cite web |title=Gila Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/gila-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .